Functional Response Characteristics of Brain Under Swallowing Task Paradigm
Launched by RUYAO LIU · May 8, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the brain reacts when people swallow different types of substances. Researchers want to understand how swallowing works in both healthy young adults and older adults. By using a special technique called functional near-infrared spectroscopy, they will look at how different areas of the brain are activated during swallowing tasks. This information could help develop better treatments for people who have swallowing disorders, known as dysphagia.
To be eligible for this study, participants should be either between 18 to 25 years old or 50 to 70 years old, with no history of neurological or swallowing issues, and must be right-handed. Women who are pregnant or anyone who may not cooperate with the study will not be able to participate. If you join the study, you can expect a comfortable environment where your brain activity will be monitored while you perform swallowing tasks. This research aims to provide valuable insights into how swallowing works and could lead to new ways to help those who struggle with swallowing.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Middle and old age group: 50\~70 years old; Young group: 18\~25 years old; Right-handed; No history of neurological, psychiatric, respiratory, or swallowing dysfunction; No brain injury, epilepsy, head and neck disease, gastroesophageal reflux disease; No cases of skull defect, head infection and skin damage that could not be detected by function near-infrared spectroscopy; Subjects signed informed consent forms in accordance with the Declaration of Helsinki.
- • -
- Exclusion Criteria:
- • pregnancy; poor patient compliance and non-cooperation with evaluation.
- • -
About Ruyao Liu
Ruyao Liu is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a strong focus on enhancing patient outcomes, Ruyao Liu oversees the design and implementation of rigorous clinical studies that adhere to the highest ethical and regulatory standards. The organization prioritizes collaboration with healthcare professionals and researchers to ensure comprehensive data collection and analysis, ultimately contributing to the development of effective therapies and treatments. Through meticulous project management and a patient-centered approach, Ruyao Liu aims to facilitate breakthroughs in healthcare and improve the quality of life for individuals worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zhengzhou, Henan, China
Zhengzhou, , China
Patients applied
Trial Officials
Xi Zeng
Study Chair
The First Affiliated Hospital of Zhengzhou University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported